REMAP-CAP and REMAP-COVID are collaborative efforts made possible by a network of global partners. High-impact relationships accelerate results for the world’s most urgent need – helping patients suffering from COVID-19.
The Global Coalition for Adaptive Research (GCAR) is the U.S. sponsor of the REMAP-COVID clinical trial. UPMC serves as the US Regional Coordinating Center. Special acknowledgement to the Breast Cancer Research Foundation for their support. See a full list of REMAP-CAP partners here.
STRATEGIC PARTNERS AND COLLABORATORS
